Trial Profile
A control labeled, double arm, comparative, multicentric, prospective, Phase III trial to compare the safety and efficacy of fixed dose combination of Cefpodoxime 200mg and Dicloxacillin 500mg with Cefpodoxime 200mg in subjects suffering with various bacterial respiratory tract infections.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 13 Apr 2013
Price :
$35
*
At a glance
- Drugs Cefpodoxime; Cefpodoxime/dicloxacillin
- Indications Bacterial infections; Respiratory tract infections
- Focus Therapeutic Use
- Sponsors Theon Pharmaceuticals
- 22 Jul 2010 New trial record